Curaleaf Holdings Inc (CURLF)
0.7600
-0.0900 (-10.59%)
OP · Last Trade: Apr 5th, 4:52 PM EDT
“We’ve accepted mommy-wine culture; why can’t we do the same with cannabis?” says Rosie Mattio, the woman behind North America's largest cannabis PR firm.
Via Benzinga · April 2, 2025
On Tuesday, Kamala Harris praised Cory Booker for his record-breaking 24-hour Senate speech protesting Trump's policies, emphasizing leadership that uplifts rather than oppresses.
Via Benzinga · April 1, 2025
Trump supported rescheduling cannabis during election but White House official confirmed no immediate changes will be made to marijuana policy.
Via Benzinga · April 1, 2025
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.
Via Benzinga · March 28, 2025
Cannabis stocks blazed higher on Thursday after Former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is "on the horizon."
Via Benzinga · March 27, 2025
The cannabis industry sees major regulatory, business and cultural shifts, with new policies, earnings and trends.
Via Benzinga · March 22, 2025
Via Benzinga · March 13, 2025

Via Benzinga · March 11, 2025

Chairman and CEO Boris Jordan pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million.
Via Stocktwits · March 4, 2025

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.
Via Benzinga · March 4, 2025

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.
Via Benzinga · March 3, 2025

This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch.
Via Benzinga · March 2, 2025

Germany's medical cannabis imports surged 4X in Q4 2024, driven by new laws. Canada & Portugal lead supply.
Via Benzinga · February 27, 2025

Via The Motley Fool · February 22, 2025

Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo.
Via Benzinga · February 14, 2025

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness.
Via Benzinga · January 8, 2025

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025